Pharma & Healthcare

Contraceptives- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

This report aims to provide a comprehensive presentation of the global market for Contraceptives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Contraceptives by region & country, by Type, and by End User.
The Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives.
Market Segmentation
By Company
Bayer AG
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
Merck & Co., Inc
Actavis, Inc.
Johnson & Johnson
Gedeon Richter
Novo Nordisk A/S
ZiZhu
Baijingyu
Huazhong
Sine
Reckitt
AbbVie
Church & Dwight
The Cooper Companies
TherapeuticsMD
Afaxys
Mithra Pharmaceuticals
Segment by Type
Pills
Injectable
Condoms
Vaginal Rings
IUDs
Subdermal Implants
Others
Segment by End User
15–24 years
25–34 years
35–44 years
Above 44 years
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Contraceptives in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Contraceptives Product Introduction
1.2 Global Contraceptives Market Size Forecast
1.2.1 Global Contraceptives Sales Value (2020-2031)
1.2.2 Global Contraceptives Sales Volume (2020-2031)
1.2.3 Global Contraceptives Sales Price (2020-2031)
1.3 Contraceptives Market Trends & Drivers
1.3.1 Contraceptives Industry Trends
1.3.2 Contraceptives Market Drivers & Opportunity
1.3.3 Contraceptives Market Challenges
1.3.4 Contraceptives Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Contraceptives Players Revenue Ranking (2024)
2.2 Global Contraceptives Revenue by Company (2020-2025)
2.3 Global Contraceptives Players Sales Volume Ranking (2024)
2.4 Global Contraceptives Sales Volume by Company Players (2020-2025)
2.5 Global Contraceptives Average Price by Company (2020-2025)
2.6 Key Manufacturers Contraceptives Manufacturing Base and Headquarters
2.7 Key Manufacturers Contraceptives Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Contraceptives
2.9 Contraceptives Market Competitive Analysis
2.9.1 Contraceptives Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Contraceptives Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Pills
3.1.2 Injectable
3.1.3 Condoms
3.1.4 Vaginal Rings
3.1.5 IUDs
3.1.6 Subdermal Implants
3.1.7 Others
3.2 Global Contraceptives Sales Value by Type
3.2.1 Global Contraceptives Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Contraceptives Sales Value, by Type (2020-2031)
3.2.3 Global Contraceptives Sales Value, by Type (%) (2020-2031)
3.3 Global Contraceptives Sales Volume by Type
3.3.1 Global Contraceptives Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Contraceptives Sales Volume, by Type (2020-2031)
3.3.3 Global Contraceptives Sales Volume, by Type (%) (2020-2031)
3.4 Global Contraceptives Average Price by Type (2020-2031)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 15–24 years
4.1.2 25–34 years
4.1.3 35–44 years
4.1.4 Above 44 years
4.2 Global Contraceptives Sales Value by End User
4.2.1 Global Contraceptives Sales Value by End User (2020 VS 2024 VS 2031)
4.2.2 Global Contraceptives Sales Value, by End User (2020-2031)
4.2.3 Global Contraceptives Sales Value, by End User (%) (2020-2031)
4.3 Global Contraceptives Sales Volume by End User
4.3.1 Global Contraceptives Sales Volume by End User (2020 VS 2024 VS 2031)
4.3.2 Global Contraceptives Sales Volume, by End User (2020-2031)
4.3.3 Global Contraceptives Sales Volume, by End User (%) (2020-2031)
4.4 Global Contraceptives Average Price by End User (2020-2031)
5 Segmentation by Region
5.1 Global Contraceptives Sales Value by Region
5.1.1 Global Contraceptives Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Contraceptives Sales Value by Region (2020-2025)
5.1.3 Global Contraceptives Sales Value by Region (2026-2031)
5.1.4 Global Contraceptives Sales Value by Region (%), (2020-2031)
5.2 Global Contraceptives Sales Volume by Region
5.2.1 Global Contraceptives Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Contraceptives Sales Volume by Region (2020-2025)
5.2.3 Global Contraceptives Sales Volume by Region (2026-2031)
5.2.4 Global Contraceptives Sales Volume by Region (%), (2020-2031)
5.3 Global Contraceptives Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Contraceptives Sales Value, 2020-2031
5.4.2 North America Contraceptives Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Contraceptives Sales Value, 2020-2031
5.5.2 Europe Contraceptives Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Contraceptives Sales Value, 2020-2031
5.6.2 Asia Pacific Contraceptives Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Contraceptives Sales Value, 2020-2031
5.7.2 South America Contraceptives Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Contraceptives Sales Value, 2020-2031
5.8.2 Middle East & Africa Contraceptives Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Contraceptives Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Contraceptives Sales Value
6.2.1 Key Countries/Regions Contraceptives Sales Value, 2020-2031
6.2.2 Key Countries/Regions Contraceptives Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Contraceptives Sales Value, 2020-2031
6.3.2 United States Contraceptives Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Contraceptives Sales Value by End User, 2024 VS 2031
6.4 Europe
6.4.1 Europe Contraceptives Sales Value, 2020-2031
6.4.2 Europe Contraceptives Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Contraceptives Sales Value by End User, 2024 VS 2031
6.5 China
6.5.1 China Contraceptives Sales Value, 2020-2031
6.5.2 China Contraceptives Sales Value by Type (%), 2024 VS 2031
6.5.3 China Contraceptives Sales Value by End User, 2024 VS 2031
6.6 Japan
6.6.1 Japan Contraceptives Sales Value, 2020-2031
6.6.2 Japan Contraceptives Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Contraceptives Sales Value by End User, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Contraceptives Sales Value, 2020-2031
6.7.2 South Korea Contraceptives Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Contraceptives Sales Value by End User, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Contraceptives Sales Value, 2020-2031
6.8.2 Southeast Asia Contraceptives Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Contraceptives Sales Value by End User, 2024 VS 2031
6.9 India
6.9.1 India Contraceptives Sales Value, 2020-2031
6.9.2 India Contraceptives Sales Value by Type (%), 2024 VS 2031
6.9.3 India Contraceptives Sales Value by End User, 2024 VS 2031
7 Company Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Information
7.1.2 Bayer AG Introduction and Business Overview
7.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bayer AG Contraceptives Product Offerings
7.1.5 Bayer AG Recent Development
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Information
7.2.2 Pfizer, Inc Introduction and Business Overview
7.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Pfizer, Inc Contraceptives Product Offerings
7.2.5 Pfizer, Inc Recent Development
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Company Information
7.3.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Offerings
7.3.5 Teva Pharmaceutical Industries Ltd Recent Development
7.4 Merck & Co., Inc
7.4.1 Merck & Co., Inc Company Information
7.4.2 Merck & Co., Inc Introduction and Business Overview
7.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merck & Co., Inc Contraceptives Product Offerings
7.4.5 Merck & Co., Inc Recent Development
7.5 Actavis, Inc.
7.5.1 Actavis, Inc. Company Information
7.5.2 Actavis, Inc. Introduction and Business Overview
7.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Actavis, Inc. Contraceptives Product Offerings
7.5.5 Actavis, Inc. Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Introduction and Business Overview
7.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Johnson & Johnson Contraceptives Product Offerings
7.6.5 Johnson & Johnson Recent Development
7.7 Gedeon Richter
7.7.1 Gedeon Richter Company Information
7.7.2 Gedeon Richter Introduction and Business Overview
7.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Gedeon Richter Contraceptives Product Offerings
7.7.5 Gedeon Richter Recent Development
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Company Information
7.8.2 Novo Nordisk A/S Introduction and Business Overview
7.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Novo Nordisk A/S Contraceptives Product Offerings
7.8.5 Novo Nordisk A/S Recent Development
7.9 ZiZhu
7.9.1 ZiZhu Company Information
7.9.2 ZiZhu Introduction and Business Overview
7.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 ZiZhu Contraceptives Product Offerings
7.9.5 ZiZhu Recent Development
7.10 Baijingyu
7.10.1 Baijingyu Company Information
7.10.2 Baijingyu Introduction and Business Overview
7.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Baijingyu Contraceptives Product Offerings
7.10.5 Baijingyu Recent Development
7.11 Huazhong
7.11.1 Huazhong Company Information
7.11.2 Huazhong Introduction and Business Overview
7.11.3 Huazhong Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Huazhong Contraceptives Product Offerings
7.11.5 Huazhong Recent Development
7.12 Sine
7.12.1 Sine Company Information
7.12.2 Sine Introduction and Business Overview
7.12.3 Sine Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Sine Contraceptives Product Offerings
7.12.5 Sine Recent Development
7.13 Reckitt
7.13.1 Reckitt Company Information
7.13.2 Reckitt Introduction and Business Overview
7.13.3 Reckitt Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Reckitt Contraceptives Product Offerings
7.13.5 Reckitt Recent Development
7.14 AbbVie
7.14.1 AbbVie Company Information
7.14.2 AbbVie Introduction and Business Overview
7.14.3 AbbVie Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 AbbVie Contraceptives Product Offerings
7.14.5 AbbVie Recent Development
7.15 Church & Dwight
7.15.1 Church & Dwight Company Information
7.15.2 Church & Dwight Introduction and Business Overview
7.15.3 Church & Dwight Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Church & Dwight Contraceptives Product Offerings
7.15.5 Church & Dwight Recent Development
7.16 The Cooper Companies
7.16.1 The Cooper Companies Company Information
7.16.2 The Cooper Companies Introduction and Business Overview
7.16.3 The Cooper Companies Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 The Cooper Companies Contraceptives Product Offerings
7.16.5 The Cooper Companies Recent Development
7.17 TherapeuticsMD
7.17.1 TherapeuticsMD Company Information
7.17.2 TherapeuticsMD Introduction and Business Overview
7.17.3 TherapeuticsMD Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 TherapeuticsMD Contraceptives Product Offerings
7.17.5 TherapeuticsMD Recent Development
7.18 Afaxys
7.18.1 Afaxys Company Information
7.18.2 Afaxys Introduction and Business Overview
7.18.3 Afaxys Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Afaxys Contraceptives Product Offerings
7.18.5 Afaxys Recent Development
7.19 Mithra Pharmaceuticals
7.19.1 Mithra Pharmaceuticals Company Information
7.19.2 Mithra Pharmaceuticals Introduction and Business Overview
7.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Mithra Pharmaceuticals Contraceptives Product Offerings
7.19.5 Mithra Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Contraceptives Industrial Chain
8.2 Contraceptives Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Contraceptives Sales Model
8.5.2 Sales Channel
8.5.3 Contraceptives Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Contraceptives Market Trends
Table 2. Contraceptives Market Drivers & Opportunity
Table 3. Contraceptives Market Challenges
Table 4. Contraceptives Market Restraints
Table 5. Global Contraceptives Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Contraceptives Revenue Market Share by Company (2020-2025)
Table 7. Global Contraceptives Sales Volume by Company (2020-2025) & (M Units)
Table 8. Global Contraceptives Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Contraceptives Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Contraceptives Manufacturing Base and Headquarters
Table 11. Key Manufacturers Contraceptives Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Contraceptives
Table 13. Global Contraceptives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptives as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Contraceptives Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Contraceptives Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Contraceptives Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Contraceptives Sales Market Share in Value by Type (2020-2025)
Table 20. Global Contraceptives Sales Market Share in Value by Type (2026-2031)
Table 21. Global Contraceptives Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)
Table 22. Global Contraceptives Sales Volume by Type (2020-2025) & (M Units)
Table 23. Global Contraceptives Sales Volume by Type (2026-2031) & (M Units)
Table 24. Global Contraceptives Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Contraceptives Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Contraceptives Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Contraceptives Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Contraceptives Sales Value by End User: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Contraceptives Sales Value by End User (2020-2025) & (US$ Million)
Table 30. Global Contraceptives Sales Value by End User (2026-2031) & (US$ Million)
Table 31. Global Contraceptives Sales Market Share in Value by End User (2020-2025)
Table 32. Global Contraceptives Sales Market Share in Value by End User (2026-2031)
Table 33. Global Contraceptives Sales Volume by End User: 2020 VS 2024 VS 2031 (M Units)
Table 34. Global Contraceptives Sales Volume by End User (2020-2025) & (M Units)
Table 35. Global Contraceptives Sales Volume by End User (2026-2031) & (M Units)
Table 36. Global Contraceptives Sales Market Share in Volume by End User (2020-2025)
Table 37. Global Contraceptives Sales Market Share in Volume by End User (2026-2031)
Table 38. Global Contraceptives Price by End User (2020-2025) & (USD/Unit)
Table 39. Global Contraceptives Price by End User (2026-2031) & (USD/Unit)
Table 40. Global Contraceptives Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Contraceptives Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Contraceptives Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Contraceptives Sales Value by Region (2020-2025) & (%)
Table 44. Global Contraceptives Sales Value by Region (2026-2031) & (%)
Table 45. Global Contraceptives Sales Volume by Region (M Units): 2020 VS 2024 VS 2031
Table 46. Global Contraceptives Sales Volume by Region (2020-2025) & (M Units)
Table 47. Global Contraceptives Sales Volume by Region (2026-2031) & (M Units)
Table 48. Global Contraceptives Sales Volume by Region (2020-2025) & (%)
Table 49. Global Contraceptives Sales Volume by Region (2026-2031) & (%)
Table 50. Global Contraceptives Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Contraceptives Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Contraceptives Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Contraceptives Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Contraceptives Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Contraceptives Sales Volume, (2020-2025) & (M Units)
Table 56. Key Countries/Regions Contraceptives Sales Volume, (2026-2031) & (M Units)
Table 57. Bayer AG Company Information
Table 58. Bayer AG Introduction and Business Overview
Table 59. Bayer AG Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Bayer AG Contraceptives Product Offerings
Table 61. Bayer AG Recent Development
Table 62. Pfizer, Inc Company Information
Table 63. Pfizer, Inc Introduction and Business Overview
Table 64. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Pfizer, Inc Contraceptives Product Offerings
Table 66. Pfizer, Inc Recent Development
Table 67. Teva Pharmaceutical Industries Ltd Company Information
Table 68. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 69. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Teva Pharmaceutical Industries Ltd Contraceptives Product Offerings
Table 71. Teva Pharmaceutical Industries Ltd Recent Development
Table 72. Merck & Co., Inc Company Information
Table 73. Merck & Co., Inc Introduction and Business Overview
Table 74. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck & Co., Inc Contraceptives Product Offerings
Table 76. Merck & Co., Inc Recent Development
Table 77. Actavis, Inc. Company Information
Table 78. Actavis, Inc. Introduction and Business Overview
Table 79. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Actavis, Inc. Contraceptives Product Offerings
Table 81. Actavis, Inc. Recent Development
Table 82. Johnson & Johnson Company Information
Table 83. Johnson & Johnson Introduction and Business Overview
Table 84. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Johnson & Johnson Contraceptives Product Offerings
Table 86. Johnson & Johnson Recent Development
Table 87. Gedeon Richter Company Information
Table 88. Gedeon Richter Introduction and Business Overview
Table 89. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Gedeon Richter Contraceptives Product Offerings
Table 91. Gedeon Richter Recent Development
Table 92. Novo Nordisk A/S Company Information
Table 93. Novo Nordisk A/S Introduction and Business Overview
Table 94. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Novo Nordisk A/S Contraceptives Product Offerings
Table 96. Novo Nordisk A/S Recent Development
Table 97. ZiZhu Company Information
Table 98. ZiZhu Introduction and Business Overview
Table 99. ZiZhu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. ZiZhu Contraceptives Product Offerings
Table 101. ZiZhu Recent Development
Table 102. Baijingyu Company Information
Table 103. Baijingyu Introduction and Business Overview
Table 104. Baijingyu Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Baijingyu Contraceptives Product Offerings
Table 106. Baijingyu Recent Development
Table 107. Huazhong Company Information
Table 108. Huazhong Introduction and Business Overview
Table 109. Huazhong Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Huazhong Contraceptives Product Offerings
Table 111. Huazhong Recent Development
Table 112. Sine Company Information
Table 113. Sine Introduction and Business Overview
Table 114. Sine Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Sine Contraceptives Product Offerings
Table 116. Sine Recent Development
Table 117. Reckitt Company Information
Table 118. Reckitt Introduction and Business Overview
Table 119. Reckitt Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Reckitt Contraceptives Product Offerings
Table 121. Reckitt Recent Development
Table 122. AbbVie Company Information
Table 123. AbbVie Introduction and Business Overview
Table 124. AbbVie Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. AbbVie Contraceptives Product Offerings
Table 126. AbbVie Recent Development
Table 127. Church & Dwight Company Information
Table 128. Church & Dwight Introduction and Business Overview
Table 129. Church & Dwight Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Church & Dwight Contraceptives Product Offerings
Table 131. Church & Dwight Recent Development
Table 132. The Cooper Companies Company Information
Table 133. The Cooper Companies Introduction and Business Overview
Table 134. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. The Cooper Companies Contraceptives Product Offerings
Table 136. The Cooper Companies Recent Development
Table 137. TherapeuticsMD Company Information
Table 138. TherapeuticsMD Introduction and Business Overview
Table 139. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. TherapeuticsMD Contraceptives Product Offerings
Table 141. TherapeuticsMD Recent Development
Table 142. Afaxys Company Information
Table 143. Afaxys Introduction and Business Overview
Table 144. Afaxys Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Afaxys Contraceptives Product Offerings
Table 146. Afaxys Recent Development
Table 147. Mithra Pharmaceuticals Company Information
Table 148. Mithra Pharmaceuticals Introduction and Business Overview
Table 149. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Mithra Pharmaceuticals Contraceptives Product Offerings
Table 151. Mithra Pharmaceuticals Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Contraceptives Downstream Customers
Table 155. Contraceptives Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources


List of Figures
Figure 1. Contraceptives Product Picture
Figure 2. Global Contraceptives Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Contraceptives Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Contraceptives Sales Volume (2020-2031) & (M Units)
Figure 5. Global Contraceptives Sales Price (2020-2031) & (USD/Unit)
Figure 6. Contraceptives Report Years Considered
Figure 7. Global Contraceptives Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Contraceptives Players Sales Volume Ranking (2024) & (M Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Contraceptives Revenue in 2024
Figure 10. Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Pills Picture
Figure 12. Injectable Picture
Figure 13. Condoms Picture
Figure 14. Vaginal Rings Picture
Figure 15. IUDs Picture
Figure 16. Subdermal Implants Picture
Figure 17. Others Picture
Figure 18. Global Contraceptives Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Contraceptives Sales Value Market Share by Type, 2024 & 2031
Figure 20. Global Contraceptives Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)
Figure 21. Global Contraceptives Sales Volume Market Share by Type, 2024 & 2031
Figure 22. Global Contraceptives Price by Type (2020-2031) & (USD/Unit)
Figure 23. Product Picture of 15–24 years
Figure 24. Product Picture of 25–34 years
Figure 25. Product Picture of 35–44 years
Figure 26. Product Picture of Above 44 years
Figure 27. Global Contraceptives Sales Value by End User (2020 VS 2024 VS 2031) & (US$ Million)
Figure 28. Global Contraceptives Sales Value Market Share by End User, 2024 & 2031
Figure 29. Global Contraceptives Sales Volume by End User (2020 VS 2024 VS 2031) & (M Units)
Figure 30. Global Contraceptives Sales Volume Market Share by End User, 2024 & 2031
Figure 31. Global Contraceptives Price by End User (2020-2031) & (USD/Unit)
Figure 32. North America Contraceptives Sales Value (2020-2031) & (US$ Million)
Figure 33. North America Contraceptives Sales Value by Country (%), 2024 VS 2031
Figure 34. Europe Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Contraceptives Sales Value by Country (%), 2024 VS 2031
Figure 36. Asia Pacific Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Contraceptives Sales Value by Region (%), 2024 VS 2031
Figure 38. South America Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 39. South America Contraceptives Sales Value by Country (%), 2024 VS 2031
Figure 40. Middle East & Africa Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Contraceptives Sales Value by Country (%), 2024 VS 2031
Figure 42. Key Countries/Regions Contraceptives Sales Value (%), (2020-2031)
Figure 43. Key Countries/Regions Contraceptives Sales Volume (%), (2020-2031)
Figure 44. United States Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 45. United States Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 46. United States Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 47. Europe Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 48. Europe Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 49. Europe Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 50. China Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 51. China Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 52. China Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 53. Japan Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 54. Japan Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 55. Japan Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 56. South Korea Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 57. South Korea Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 58. South Korea Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 59. Southeast Asia Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 60. Southeast Asia Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 61. Southeast Asia Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 62. India Contraceptives Sales Value, (2020-2031) & (US$ Million)
Figure 63. India Contraceptives Sales Value by Type (%), 2024 VS 2031
Figure 64. India Contraceptives Sales Value by End User (%), 2024 VS 2031
Figure 65. Contraceptives Industrial Chain
Figure 66. Contraceptives Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies